Stockreport

Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]

Design Therapeutics, Inc.  (DSGN) 
PDF Reported EPS is $-0.21, expectations were $-0.32. DSGN isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here [Read more]